Antibody-Based Therapy Shows Promise Against Stomach Cancer - U.S. News & World Report

U.S. News & World Report

Antibody-Based Therapy Shows Promise Against Stomach Cancer U.S. News & World Report SUNDAY, June 5, 2016 (HealthDay News) -- An experimental therapy based on immune-system antibodies is helping some people with advanced stomach cancer live longer, a new study finds. The phase 2 clinical trial, involving 161 patients, focused on an ... Ganymed's IMAB362 Extends Survival in Gastric CancerPR Newswire (press release) Billionaire-backed Ganymed grabs ASCO spotlight with gastric cancer drugFierceBiotech all 3 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNE_eRfhIrZCyPdzMETgWIZyDUdi5w&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779127427691&ei=gApVV9DQFNmM3wHqqIbwCA&url=http://health.usnews.com/health-care/articles/2016-06-05/antibody-based-therapy-shows-promise-against-stomach-cancer
via IFTTT